Track the 지엘팜텍 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 지엘팜텍 has published 14 insider filings. Market capitalisation: €63.6bn. The latest transaction was disclosed on 19 June 2026 (Other). Among the most active insiders: 지엘팜텍. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
14 of 14 declarations
지엘팜텍 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It specializes in the development and marketing of pharmaceutical products.